98 related articles for article (PubMed ID: 16799643)
1. Differential regulation of CXC ligand 1 transcription in melanoma cell lines by poly(ADP-ribose) polymerase-1.
Amiri KI; Ha HC; Smulson ME; Richmond A
Oncogene; 2006 Dec; 25(59):7714-22. PubMed ID: 16799643
[TBL] [Abstract][Full Text] [Related]
2. A role for poly(ADP-ribose) polymerase in the transcriptional regulation of the melanoma growth stimulatory activity (CXCL1) gene expression.
Nirodi C; NagDas S; Gygi SP; Olson G; Aebersold R; Richmond A
J Biol Chem; 2001 Mar; 276(12):9366-74. PubMed ID: 11112786
[TBL] [Abstract][Full Text] [Related]
3. Cooperative role of NF-{kappa}B and poly(ADP-ribose) polymerase 1 (PARP-1) in the TNF-induced inhibition of PHEX expression in osteoblasts.
Majewski PM; Thurston RD; Ramalingam R; Kiela PR; Ghishan FK
J Biol Chem; 2010 Nov; 285(45):34828-38. PubMed ID: 20817730
[TBL] [Abstract][Full Text] [Related]
4. Poly(ADP-ribose) polymerase-1 down-regulates BRCA2 expression through the BRCA2 promoter.
Wang J; Bian C; Li J; Couch FJ; Wu K; Zhao RC
J Biol Chem; 2008 Dec; 283(52):36249-56. PubMed ID: 18990703
[TBL] [Abstract][Full Text] [Related]
5. Role of CXCL1 in tumorigenesis of melanoma.
Dhawan P; Richmond A
J Leukoc Biol; 2002 Jul; 72(1):9-18. PubMed ID: 12101257
[TBL] [Abstract][Full Text] [Related]
6. Duplication of CXC chemokine genes on chromosome 4q13 in a melanoma-prone family.
Yang XR; Brown K; Landi MT; Ghiorzo P; Badenas C; Xu M; Hayward NK; Calista D; Landi G; Bruno W; Bianchi-Scarrà G; Aguilera P; Puig S; Goldstein AM; Tucker MA
Pigment Cell Melanoma Res; 2012 Mar; 25(2):243-7. PubMed ID: 22225770
[TBL] [Abstract][Full Text] [Related]
7. Emerging Roles of Post-Translational Modifications in Skin Diseases: Current Knowledge, Challenges and Future Perspectives.
Yang L; Yan Y
J Inflamm Res; 2022; 15():965-975. PubMed ID: 35177923
[TBL] [Abstract][Full Text] [Related]
8.
Korbecki J; Barczak K; Gutowska I; Chlubek D; Baranowska-Bosiacka I
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054978
[No Abstract] [Full Text] [Related]
9. Repeated treatments of Capan-1 cells with PARP1 and Chk1 inhibitors promote drug resistance, migration and invasion.
Guo N; Li MZ; Wang LM; Chen HD; Song SS; Miao ZH; He JX
Cancer Biol Ther; 2022 Dec; 23(1):69-82. PubMed ID: 35000525
[TBL] [Abstract][Full Text] [Related]
10. PARP1 as a Marker of an Aggressive Clinical Phenotype in Cutaneous Melanoma-A Clinical and an In Vitro Study.
Kupczyk P; Simiczyjew A; Marczuk J; Dratkiewicz E; Beberok A; Rok J; Pieniazek M; Biecek P; Nevozhay D; Slowikowski B; Chodaczek G; Wrzesniok D; Nowak D; Donizy P
Cells; 2021 Jan; 10(2):. PubMed ID: 33572647
[TBL] [Abstract][Full Text] [Related]
11. Minireview Exploring the Biological Cycle of Vitamin B3 and Its Influence on Oxidative Stress: Further Molecular and Clinical Aspects.
Doroftei B; Ilie OD; Cojocariu RO; Ciobica A; Maftei R; Grab D; Anton E; McKenna J; Dhunna N; Simionescu G
Molecules; 2020 Jul; 25(15):. PubMed ID: 32707945
[TBL] [Abstract][Full Text] [Related]
12. The Role of PARPs in Inflammation-and Metabolic-Related Diseases: Molecular Mechanisms and Beyond.
Ke Y; Wang C; Zhang J; Zhong X; Wang R; Zeng X; Ba X
Cells; 2019 Sep; 8(9):. PubMed ID: 31500199
[TBL] [Abstract][Full Text] [Related]
13. Poly(ADP-ribosyl)ation of OVOL2 regulates aneuploidy and cell death in cancer cells.
Zhang R; Hong JJ; Yang Q; Ong CT; Li BA; Liou YC
Oncogene; 2019 Apr; 38(15):2750-2766. PubMed ID: 30542118
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanoma.
Wouters J; Vizoso M; Martinez-Cardus A; Carmona FJ; Govaere O; Laguna T; Joseph J; Dynoodt P; Aura C; Foth M; Cloots R; van den Hurk K; Balint B; Murphy IG; McDermott EW; Sheahan K; Jirström K; Nodin B; Mallya-Udupi G; van den Oord JJ; Gallagher WM; Esteller M
BMC Med; 2017 Jun; 15(1):101. PubMed ID: 28578692
[TBL] [Abstract][Full Text] [Related]
15. Progesterone and the Repression of Myometrial Inflammation: The Roles of MKP-1 and the AP-1 System.
Lei K; Georgiou EX; Chen L; Yulia A; Sooranna SR; Brosens JJ; Bennett PR; Johnson MR
Mol Endocrinol; 2015 Oct; 29(10):1454-67. PubMed ID: 26280733
[TBL] [Abstract][Full Text] [Related]
16. TGF-β Negatively Regulates CXCL1 Chemokine Expression in Mammary Fibroblasts through Enhancement of Smad2/3 and Suppression of HGF/c-Met Signaling Mechanisms.
Fang WB; Mafuvadze B; Yao M; Zou A; Portsche M; Cheng N
PLoS One; 2015; 10(8):e0135063. PubMed ID: 26252654
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of chemokine expression in ovarian cancer.
Singha B; Gatla HR; Vancurova I
Biomolecules; 2015 Mar; 5(1):223-43. PubMed ID: 25790431
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Chemokine (C-X-C) ligand 1 (CXCL1) associated with tumor progression and poor prognosis in hepatocellular carcinoma.
Cao Z; Fu B; Deng B; Zeng Y; Wan X; Qu L
Cancer Cell Int; 2014; 14(1):86. PubMed ID: 25298747
[TBL] [Abstract][Full Text] [Related]
19. Functional Aspects of PARP1 in DNA Repair and Transcription.
Ko HL; Ren EC
Biomolecules; 2012 Nov; 2(4):524-48. PubMed ID: 24970148
[TBL] [Abstract][Full Text] [Related]
20. Primary 1,25-dihydroxyvitamin D3 response of the interleukin 8 gene cluster in human monocyte- and macrophage-like cells.
Ryynänen J; Carlberg C
PLoS One; 2013; 8(10):e78170. PubMed ID: 24250750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
